サワイグループホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/02/02 | 4,020 | 4,035 | 3,935 | 3,935 | -80 | -2% | 118,400 |
| 2023/02/01 | 4,045 | 4,050 | 4,005 | 4,015 | ±0 | ±0% | 52,600 |
| 2023/01/31 | 4,000 | 4,030 | 3,985 | 4,015 | +25 | +0.6% | 80,800 |
| 2023/01/30 | 3,990 | 4,005 | 3,970 | 3,990 | +20 | +0.5% | 107,000 |
| 2023/01/27 | 3,990 | 4,000 | 3,960 | 3,970 | +10 | +0.3% | 72,100 |
| 2023/01/26 | 3,950 | 3,970 | 3,940 | 3,960 | +25 | +0.6% | 63,000 |
| 2023/01/25 | 3,930 | 3,960 | 3,930 | 3,935 | -10 | -0.3% | 54,600 |
| 2023/01/24 | 3,925 | 3,955 | 3,910 | 3,945 | +20 | +0.5% | 45,600 |
| 2023/01/23 | 3,940 | 3,960 | 3,920 | 3,925 | +10 | +0.3% | 43,800 |
| 2023/01/20 | 3,915 | 3,935 | 3,890 | 3,915 | +15 | +0.4% | 47,200 |
| 2023/01/19 | 3,945 | 3,945 | 3,900 | 3,900 | -35 | -0.9% | 68,100 |
| 2023/01/18 | 3,910 | 3,945 | 3,890 | 3,935 | +30 | +0.8% | 75,400 |
| 2023/01/17 | 3,960 | 3,960 | 3,890 | 3,905 | -30 | -0.8% | 68,000 |
| 2023/01/16 | 3,860 | 3,945 | 3,855 | 3,935 | +55 | +1.4% | 60,000 |
| 2023/01/13 | 3,880 | 3,905 | 3,870 | 3,880 | -20 | -0.5% | 67,500 |
| 2023/01/12 | 3,910 | 3,925 | 3,885 | 3,900 | -25 | -0.6% | 57,800 |
| 2023/01/11 | 3,935 | 3,965 | 3,920 | 3,925 | +25 | +0.6% | 63,900 |
| 2023/01/10 | 3,950 | 3,965 | 3,895 | 3,900 | -45 | -1.1% | 67,100 |
| 2023/01/06 | 3,960 | 3,980 | 3,935 | 3,945 | -25 | -0.6% | 64,900 |
| 2023/01/05 | 3,980 | 3,990 | 3,955 | 3,970 | -45 | -1.1% | 93,300 |
| 2023/01/04 | 4,095 | 4,095 | 4,015 | 4,015 | -110 | -2.7% | 67,300 |
| 2022/12/30 | 4,130 | 4,165 | 4,120 | 4,125 | -35 | -0.8% | 43,500 |
| 2022/12/29 | 4,175 | 4,175 | 4,105 | 4,160 | -40 | -1% | 70,400 |
| 2022/12/28 | 4,145 | 4,205 | 4,140 | 4,200 | +60 | +1.4% | 88,800 |
| 2022/12/27 | 4,135 | 4,165 | 4,130 | 4,140 | +25 | +0.6% | 37,400 |
| 2022/12/26 | 4,150 | 4,165 | 4,100 | 4,115 | -30 | -0.7% | 54,200 |
| 2022/12/23 | 4,085 | 4,165 | 4,085 | 4,145 | +25 | +0.6% | 84,400 |
| 2022/12/22 | 4,050 | 4,125 | 4,040 | 4,120 | +55 | +1.4% | 76,900 |
| 2022/12/21 | 4,055 | 4,115 | 4,030 | 4,065 | ±0 | ±0% | 111,400 |
| 2022/12/20 | 4,080 | 4,130 | 4,020 | 4,065 | +15 | +0.4% | 105,900 |
| 2022/12/19 | 4,050 | 4,065 | 4,020 | 4,050 | -15 | -0.4% | 89,300 |
| 2022/12/16 | 4,090 | 4,115 | 4,060 | 4,065 | -30 | -0.7% | 153,000 |
| 2022/12/15 | 4,095 | 4,105 | 4,075 | 4,095 | +10 | +0.2% | 79,700 |
| 2022/12/14 | 4,105 | 4,105 | 4,075 | 4,085 | -5 | -0.1% | 68,200 |
| 2022/12/13 | 4,115 | 4,125 | 4,080 | 4,090 | ±0 | ±0% | 91,900 |
| 2022/12/12 | 4,125 | 4,125 | 4,065 | 4,090 | -60 | -1.4% | 101,700 |
| 2022/12/09 | 4,120 | 4,165 | 4,100 | 4,150 | +75 | +1.8% | 98,600 |
| 2022/12/08 | 4,120 | 4,120 | 4,030 | 4,075 | -5 | -0.1% | 135,900 |
| 2022/12/07 | 4,030 | 4,120 | 4,010 | 4,080 | +35 | +0.9% | 108,500 |
| 2022/12/06 | 4,065 | 4,090 | 4,025 | 4,045 | -40 | -1% | 159,100 |
| 2022/12/05 | 4,130 | 4,130 | 4,060 | 4,085 | -45 | -1.1% | 100,100 |
| 2022/12/02 | 4,230 | 4,230 | 4,110 | 4,130 | -125 | -2.9% | 127,600 |
| 2022/12/01 | 4,225 | 4,275 | 4,190 | 4,255 | +15 | +0.4% | 173,200 |
| 2022/11/30 | 4,265 | 4,280 | 4,230 | 4,240 | -70 | -1.6% | 181,900 |
| 2022/11/29 | 4,380 | 4,380 | 4,280 | 4,310 | -90 | -2% | 178,800 |
| 2022/11/28 | 4,420 | 4,435 | 4,375 | 4,400 | +15 | +0.3% | 129,500 |
| 2022/11/25 | 4,295 | 4,400 | 4,295 | 4,385 | +90 | +2.1% | 145,000 |
| 2022/11/24 | 4,280 | 4,310 | 4,260 | 4,295 | +25 | +0.6% | 129,300 |
| 2022/11/22 | 4,230 | 4,300 | 4,230 | 4,270 | +60 | +1.4% | 119,600 |
| 2022/11/21 | 4,205 | 4,230 | 4,170 | 4,210 | +15 | +0.4% | 103,000 |
551～
600
件表示中 / 1000件
類似銘柄と比較する
現在ご覧いただいている「サワイＧＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
